Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
09/2003
09/11/2003US20030171591 Process for producing optically active sulfoxide derivative
09/11/2003US20030171584 6-Substituted pyrido-pyrimidines
09/11/2003US20030171541 Selective binding agents, vectors, host cells, and methods for producing GPCR polypeptides; diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with GPCR polypeptides
09/11/2003US20030171438 Method for treatment of external secretion disorders
09/11/2003US20030171432 Treating irrtable bowel syndrome or disease
09/11/2003US20030171409 Novel delta dicarbonyl compounds and methods for using the same
09/11/2003US20030171404 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
09/11/2003US20030171400 Rheumatic diseases; osteoporosis; multiple sclerosis; autoimmune disease; joint replacements
09/11/2003US20030171392 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
09/11/2003US20030171389 Anticancer agents; bone disorders; antiarthritic agents
09/11/2003US20030171384 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
09/11/2003US20030171383 Administering adenosine A2 receptor antagonist
09/11/2003US20030171382 Pharmaceutical composition for regeneration of cirrhotic liver
09/11/2003US20030171380 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
09/11/2003US20030171362 Amino-tetralin derivatives as muscarinic receptor antagonists
09/11/2003US20030171361 Treatment of impotence, sexual dysfunction in female, stable, unstable and variant angina, hypertension, pulmonary hypertension, congestive heart failure, atherosclerosis
09/11/2003US20030171359 Suitable for treatment of illnesses characterised by excessive or abnormal cell proliferation; viral, bacterial, fungal and/or parasitic infections, skin diseases, bone diseases, cardiovascular diseases
09/11/2003US20030171354 Indole derivatives
09/11/2003US20030171352 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
09/11/2003US20030171309 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
09/11/2003US20030171276 Capable of inhibiting the binding of hepatitis virus and a target cell, thereby preventing or treating chronic hepatitis; and a fusion interferon capable of still more improving a viral clearance ratio at the termination of
09/11/2003US20030171269 Novel epidermal growth factor protein and gene, and methods of use therefor
09/11/2003US20030171267 Albumin fusion proteins
09/11/2003US20030170859 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders
09/11/2003US20030170840 Genomic mammary amyloid a sequence
09/11/2003US20030170685 Canine hepatocyte growth factor
09/11/2003US20030170648 Autoimmune diseases; inflammatory bowel disease; multiple sclerosis; rheumatic diseases; modulate gene expression
09/11/2003US20030170329 Cytokine production inhibitors, agents for protecting and promoting liver funtion, anti-inflammatory agents, immunosuppressants, drugs, cosmetics, foods and food materials
09/11/2003US20030170315 Bioactivation of iron salt, especially an ferric ferrous salt, by adding a magnesium salt (MgCl2); useful as a medicine to treat diseases such as diabetes, freshness preservative agent, and animal and plant growth promoter
09/11/2003US20030170300 Combination chemotherapy
09/11/2003US20030170289 Injectable depot compositions and uses thereof
09/11/2003US20030170286 Codrug with at least two constituent moieties cleavably linked covalently to one another; dimensioned to position two radiation seeds a predetermined distance apart.
09/11/2003US20030170274 Activation of HCV-specific T cells
09/11/2003US20030170264 Stabilisation of plasmid inheritance in bacteria
09/11/2003US20030170262 Immunogenic detoxified mutant E. coli LT-A toxin
09/11/2003US20030170248 Constant region contains a human immunoglobulin and variable region contains a non-human immunoglobulin variable region; especially treating an infection caused by Enterohemorrhagic Escherichia coli
09/11/2003US20030170233 Treating Autoimmune Diseases with Humanized Anti-CD40L Antibody
09/11/2003US20030170217 Bifidobacterium in the treatment of inflammatory disease
09/11/2003US20030170185 To enhance the remineralization
09/11/2003US20030170184 Administering to a mammal in need of such treatment a lactic bacteria strain that is exogenous to oral microflora, which strain is selected for its ability to adhere to teeth pellicle and to produce a growth inhibition factor
09/10/2003EP1342765A2 Hot melt pressure sensitive adhesives for disposable articles
09/10/2003EP1342721A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
09/10/2003EP1342474A1 The use of proline, poly-proline peptides and proline-rich proteins to quench reactive oxygen species
09/10/2003EP1341920A2 Human elongase genes and uses thereof
09/10/2003EP1341915A1 Use of cells derived from embryonic stem cells for increasing transplantation tolerance and for repairing damaged tissue
09/10/2003EP1341817A2 Tff peptides
09/10/2003EP1341793A2 Crf receptor antagonists and methods relating thereto
09/10/2003EP1341792A2 Amido ether substituted imidazoquinolines
09/10/2003EP1341791A2 Thioether substituted imidazoquinolines
09/10/2003EP1341790A2 Sulfonamido ether substituted imidazoquinolines
09/10/2003EP1341789A2 Aryl ether substituted imidazoquinolines
09/10/2003EP1341782A2 Inhibitors of p38 kinase
09/10/2003EP1341770A1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors
09/10/2003EP1341767A2 Imidazole and benzimidazole caspase inhibitors and uses thereof
09/10/2003EP1341761A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-$g(g) BINDING AGENTS
09/10/2003EP1341754A1 Substituted anthranilic acids
09/10/2003EP1341753A1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
09/10/2003EP1341552A2 Treatment of immune-mediated diseases by oral administration of plasma fractions
09/10/2003EP1341539A1 Anti-inflammatory agents
09/10/2003EP1341537A2 Pharmaceutically active isoindoline derivatives
09/10/2003EP1341536A2 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine
09/10/2003EP1341528A1 Rapidly disintegrating tablet comprising an acid-labile active ingredient
09/10/2003EP1341524A2 Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
09/10/2003EP1341512A1 Rhinological agents
09/10/2003EP1169044B1 Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence
09/10/2003EP1135389B1 1,4-diazabicyclo 3.2.2]nonane derivatives, their preparation and therapeutic application
09/10/2003EP1023063B1 INDENO[1,2-c], NAPHTHO[1,2-c]- AND BENZO[6,7]CYCLOHEPTA[1,2-c]PYRAZOLE DERIVATIVES
09/10/2003EP0936906B1 Reflux inhibitors
09/10/2003EP0934264B1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
09/10/2003EP0912518B1 Substituted pyridines as selective cyclooxygenase-2 inhibitors
09/10/2003EP0896533B1 Pentafluorobenzenesulfonamides and analogs
09/10/2003CN1441807A Hepatitis B core antigen fusion proteins
09/10/2003CN1441804A Tetrahydro-heterocyclozaepinyl pyrimidine derivatives
09/10/2003CN1441803A Indoloquinazolinones
09/10/2003CN1441796A Cyclic substituted aminomethyl compounds and medicaments containing said compounds
09/10/2003CN1441791A 四唑衍生物 Tetrazole derivative
09/10/2003CN1441787A Modulators of TNF-alpha signaling
09/10/2003CN1441785A Tetrahydroixoquinoline analogs useful as growth hormone secretagogues
09/10/2003CN1441782A N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
09/10/2003CN1441781A Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
09/10/2003CN1441779A Proline derivatives and use thereof as drugs
09/10/2003CN1441776A Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives
09/10/2003CN1441770A Modified forms of pharmacologically active agents and uses therefor
09/10/2003CN1441673A 4,5-dihydro-thiazo-2-ylamine derivatives and their use as NO-synthase inhibitors
09/10/2003CN1441667A Pharmaceutical compositions
09/10/2003CN1441664A Synergistic antiplaque/antigivitis oral composition
09/10/2003CN1440978A Pyloric spirobacterium inhibitor
09/10/2003CN1440815A Ingredient and production process of Chinese medicinal digestive tract contrast medium
09/10/2003CN1440808A New use of neutral proteinase in treating hepatitis
09/10/2003CN1440802A Gastritis treating Chinese medicine
09/10/2003CN1440801A Dizziness treating Chinese medicine
09/10/2003CN1440794A Medicine for clearing away heat, purging fire-evil, calming nerves and relaxing bowels
09/10/2003CN1440792A Hepatosis treating medicine and its prepn process
09/10/2003CN1440789A Medicine for treating chronic gastritis and peptic ulcer
09/10/2003CN1440786A Nourishing health food for treating constipation
09/10/2003CN1440780A Food granule with the functions of treating hepatosis, pretecting liver and lowering blood pressure
09/10/2003CN1440778A Kidney invigorating Chinese medicine
09/10/2003CN1440772A Composite Chinese medicine for treating bloat and its prepn process and quality control method
09/10/2003CN1440771A Stomatocase treating medicine
09/10/2003CN1440770A Sheep fetus peptide capsule and its prepn process
1 ... 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 ... 1258